09:17 AM EST, 12/13/2024 (MT Newswires) -- Health care stocks were steady premarket Friday, with The Health Care Select Sector SPDR Fund ( XLV ) marginally higher and the iShares Biotechnology ETF (IBB) inactive.

BeiGene ( BGNE ) shares were up over 2% after the company said overnight it signed a global licensing deal with CSPC Zhongqi Pharmaceutical Technology for its experimental cancer therapy, SYH2039.

Geron ( GERN ) stock was over 1% higher after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of Rytelo for the treatment of adult patients with transfusion-dependent anemia due to lower risk myelodysplastic syndromes.

Candel Therapeutics ( CADL ) shares were down past 33% after the company said overnight it priced an underwritten public offering of 10 million common shares at $6 apiece and pre-funded warrants to buy up to a total of 3.3 million shares of its common stock at $5.99 per warrant to raise about $80 million in gross proceeds.